Bioventus Inc

Healthcare · Medical Devices

13.30$ +3.1% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Bioventus Inc (BVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 673 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BVS
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	811	811	794	792	769	728	691	707	702	684	651	673
Current Assets	249	268	266	309	299	276	249	275	281	273	250	258
Cash	27	37	25	32	43	42	23	33	42	51	36	29
Cash & Short-Term Investments	27	37	25	32	43	42	23	33	42	51	36	29
Receivables	113	123	126	137	122	127	118	132	130	128	121	138
Inventory	98	91	97	88	90	92	94	96	96	82	83	80
Goodwill	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5	7.5
Intangible Assets	493	482	471	425	415	405	396	387	377	368	360	351
Total Liabilities	585	590	577	603	583	542	506	505	494	455	416	396
Current Liabilities	161	175	173	231	211	210	175	186	162	160	148	152
Short-Term Debt	20	28	36	39	39	27	37	43	11	19	19	23
Accounts Payable	18	23	19	24	17	24	19	24	27	11	24	20
Long-Term Debt	375	367	355	345	345	308	309	298	311	279	253	230
Shareholders' Equity	178	174	171	151	149	148	148	161	166	184	189	228
Retained Earnings	-315	-322	-326	-350	-355	-355	-360	-353	-350	-335	-332	-298
Shares Outstanding	63	63	63	64	65	65	66	69	69	69	70	71

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings